Protein partners of deubiquitinating enzymes

Biochemical Journal

Volumn 414, Issue 2, 2008, Pages 161-175

  Ventii, Karen H ^a   Wilkinson, Keith D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Deubiquitinating enzyme (DUB); Deubiquitination; Proteasome; Ubiquitin; Ubiquitin specific protease

Indexed keywords

CATALYSTS; CHLORINE COMPOUNDS; LAWS AND LEGISLATION; MACROMOLECULES; SCAFFOLDS; SUBSTRATES;

DEUBIQUITINATING ENZYME (DUB); DEUBIQUITINATION; PROTEASOME; UBIQUITIN; UBIQUITIN-SPECIFIC PROTEASE;

ENZYMES;

ADAPTOR PROTEIN; CYSTEINE PROTEINASE; METALLOPROTEINASE; ONCOPROTEIN; PROTEASOME; RECEPTOR PROTEIN; SCAFFOLD PROTEIN; UBIQUITIN PROTEIN LIGASE;

BINDING AFFINITY; CARCINOGENESIS; CATALYSIS; COMPLEX FORMATION; CONJUGATION; ENZYME ACTIVATION; ENZYME SPECIFICITY; GENE MUTATION; GENETIC DIFFERENCE; HUMAN; MACROMOLECULE; MALIGNANT NEOPLASTIC DISEASE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION REGULATION; UBIQUITINATION;

ENDOPEPTIDASES; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEINS; UBIQUITIN; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 50949126350     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20080798     Document Type: Review

References (165)

1. Wilkinson, K. D. (2004) Ubiquitin: a Nobel protein. Cell 119, 741-745
2. Pickart, C. M. (2001) Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533
3. Jentsch, S., Seufert, W. and Hauser, H. P. (1991) Genetic analysis of the ubiquitin system. Biochim. Biophys. Acta 1089, 127-139
4. Wilkinson, K. O. (1995) Roles of ubiquitinylation in proteolysis and cellular regulation. Annu. Rev. Nutr. 15, 161-189
5. Sigismund, S., Polo, S. and Di Fiore, P. P. (2004) Signaling through monoubiquitination. Curr. Top. Microbiol. Immunol. 286, 149-185
6. Welchman, R. L., Gordon, C. and Mayer, R. J. (2005) Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. 6, 599-609
7. Pickart, C. M. and Fushman, D. (2004) Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol, 8, 610-616
8. Amerik, A. Y. and Hochstrasser, M. (2004) Mechanism and function of deubiquitinating enzymes. Biochim. Biophys. Acta 1695, 189-207
9. Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P. Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H.. Sekido, Y. et al. (1998) BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16, 1097-1112
10. Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K. and Bernards, R. (2005) A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786
11. Gong, B. and Leznik, E. (2007) The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect. 20, 365-370
12. Di Donato, F., Chan, E. K., Askanase, A. D., Miranda-Carus, M. and Buyon, J. P. (2001) Interaction between 52 kDa SSA/Ro and deubiquitinating enzyme UnpEL: a clue to function. Int. J. Biochem. Cell Biol. 33, 924-934
13. Sulea, T., Lindner. H. A. and Menard, R. (2006) Structural aspects of recently discovered viral deubiquitinating activities. Biol. Chem. 387, 853-862
14. Catic, A., Misaghi, S., Korbel, G. A. and Ploegh, H. L. (2007) ElaD, a deubiquitinating protease expressed by E. coli. PLoS ONE 2, e381
15. Hu, M., Li, P, Li, M., Li, W., Yao, T., Wu, J. W., Gu, W., Cohen, R. E. and Shi, Y. (2002) Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 111, 1041-1054
16. Johnston, S. C,, Riddle, S. M., Cohen, R. E. and Hill, C. P. (1999) Structural basis for the specificity of ubiquitin C-terminal hydrolases. EMBO J. 18, 3877-3887
17. Hu, M., Li, P., Song, L., Jeffrey, P. D., Chenova, T. A., Wilkinson, K. D., Cohen, R. E. and Shi, Y. (2005) Structure and mechanisms of the proteasome-associated deubiquitinating enzyme USP14. EMBO J. 24, 3747-3756
18. Avvakumov, G. V., Walker, J. R., Xue, S., Finerty Jr, P. J., Mackenzie, F., Newman, E. M. and Dhe-Paganon, S. (2006) Amino-terminal dimerization, NRDP1-rhodanese interaction, and inhibited catalytic domain conformation of the ubiquitin-specific protease 8 (USP8). J. Biol. Chem. 281, 38061-38070
19. Zhang, Y., Zhou, X. and Huang, P. (2007) Fanconi anemia and ubiquitination. J. Genet. Genomics 34, 573-580
20. Nijman, S. M., Huang, T. T., Dirac, A. M., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D. and Bernards, R. (2005) The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17, 331-339
21. Fujiwara, T., Saito, A., Suzuki, M., Shinomiya, H., Suzuki, T., Takahashi, E., Tanigami, A., Ichiyama, A., Chung, C. H., Nakamura, Y. and Tanaka, K. (1998) Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. Genomics 54, 155-158
22. Cohn, M. A., Kowal, P., Yang, K., Haas, W., Huang, T. T., Gygi, S. P. and D'Andrea, A. D. (2007) A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28, 786-797
23. Priolo, C., Tang, D., Brahamandan, M., Benassi, B., Sicinska, E. Ogino, S., Farsetti, A., Porrello, A., Finn, S., Zimmermann, J. et al. (2006) The isopeptidase USP2a protects human prostate cancer from apoptosis. Cancer Res. 66, 8625-8632
24. Stevenson, L. F., Sparks, A., Allende-Vega, N., Xirodimas, D. P., Lane, D. P. and Saville, M. K. (2007) The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26, 976-986
25. Lin, H., Keriel, A., Morales, C. R., Bedard, N., Zhao, Q., Hingamp, P., Lefrancois, S., Combaret, L. and Wing, S. S. (2000) Divergent N-terminal sequences target an inducible testis deubiquitinating enzyme to distinct subcellular structures. Mol. Cell. Biol. 20, 6568-6578
26. Rotter, V., Schwartz, D., Almon, E., Goldfinger, N., Kapon, A., Meshorer, A., Donehower, L. A. and Levine, A. J. (1993) Mice with reduced levels of p53 protein exhibit the testicular giant-cell degenerative syndrome. Proc. Natl. Acad. Sci. U.S.A. 90, 9075-9079
27. Schwartz, D., Goldfinger, N., Kam, Z. and Rotter, V. (1999) p53 controls low DNA damage-dependent premeiotic checkpoint and facilitates DNA repair during spermatogenesis. Cell. Growth Differ. 10, 665-675
28. Coutts, A. S. and La Thangue, N. B. (2007) Mdm2 widens its repertoire. Cell Cycle 6, 827-829
29. Cheon, K. W. and Baek, K. H. (2006) HAUSP as a therapeutic target for hematopoietic tumors. Int. J. Oncol. 28, 1209-1215
30. Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J. and Gu, W. (2002) Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416, 648-653
31. Gousseva, N. and Baker, R. T. (2003) Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-Us45 and Usp2-Us69. Gene Exp. 11, 163-179
32. Graner, E., Tang, D., Rossi, S., Baron, A., Migita, T., Weinstein, L. J., Lechpammer, M., Huesken, D., Zimmermann, J., Signoretti, S. and Loda, M. (2004) The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. Cancer Cell 5, 253-261
33. Baron, A., Migita, T., Tang, D. and Loda, M. (2004) Fatty acid synthase: a metabolic oncogene in prostate cancer? J. Cell. Biachem. 91, 47-53
34. Renatus, M., Parrado, S. G., D'Arcy, A., Eidhoff, U., Gerhartz, B., Hassiepen, U., Pierrat, B., Riedl, R., Vinzenz, D., Worpenberg, S. and Kroemer, M. (2006) Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure 14, 1293-1302
35. Gray, D. A., Inazawa, J., Gupta, K., Wong, A., Ueda, R. and Takahashi, T. (1995) Elevated expression of Unph, a proto-oncogene at 3p21.3, in human lung tumors. Oncogene 10, 2179-2183
36. Gupta, K., Copeland, N. G., Gilbert, D. J., Jenkins, N. A. and Gray, D. A. (1993) Unp, a mouse gene related to the tre oncogene. Oncogene 8, 2307-2310
37. Wada, K. and Kamitani, T. (2006) UnpEL/Usp4 is ubiquitinated by Ro52 and deubiquitinated by itself. Biochem. Biophys. Res. Commun. 342, 253-258
38. Wada, K., Tanji, K. and Kamitani, T. (2006) Oncogenic protein UnpEL/Usp4 deubiquitinates Ro52 by its isopeptidase activity. Biochem. Biophys. Res. Commun. 339, 731-736
39. Toews, M. L. (2006) Adenosine receptors find a new partner and move out. Mol. Pharmacol. 69, 1075-1078
40. Milojevic, T., Reiterer, V., Stefan, E., Korkhov, V. M., Dorostkar, M. M., Ducza, E., Ogris, E., Boehm, S., Freissmuth, M. and Nanoff, C. (2006) The ubiquitin-specific protease Usp4 regulates the cell surface level of the A2A receptor. Mol. Pharmacol. 69. 1083-1094
41. Paulding, C. A., Ruvolo, M. and Haber, D. A. (2003) The Tre2 (USP6) oncogene is a hominoid-specific gene. Proc. Natl. Acad. Sci. U.S.A. 100, 2507-2511
42. Nakamura, T., Hillova, J., Mariage-Samson, R., Onno, M., Huebner, K., Cannizzaro, L. A., Boghosian-Sell, L., Croce, C. M. and Hill, M. (1992) A novel transcriptional unit of the tre oncogene widely expressed in human cancer cells. Oncogene 7, 733-741
43. Dechamps, C., Bach, S., Portetelle, D. and Vandenbol, M. (2006) The Tre2 oncoprotein, implicated in Ewing's sarcoma, interacts with two components of the cytoskeleton. Biotechnol. Lett. 28, 223-231
44. Macera, M. J., Szabo, P., Wadgaonkar, R., Siddiqui, M. A. and Verma, R. S. (1992) Localization of the gene coding for ventricular myosin regulatory light chain (MYL2) to human chromosome 12q23-q24.3, Genomics 13, 829-831
45. Masuda-Robens, J. M., Kutney, S. N., Qi, H. and Chou, M. M. (2003) The TRE17 oncogene encodes a component of a novel effector pathway for Rho GTPases Cdc42 and Rac1 and stimulates actin remodeling. Mol. Cell. Biol. 23, 2151-2161
46. Holowaty, M. N., Sheng, Y., Nguyen, T., Arrowsmith, C. and Frappier, L. (2003) Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSR. J. Biol. Chem. 278, 47753-47761
47. Cummins, J. M. and Vogelstein, B. (2004) HAUSP is required for p53 destabilization. Cell Cycle 3, 689-692
48. Li, M., Brooks, C. L., Kon, N. and Gu, W. (2004) A dynamic role of HAUSP in the p53-Mdm2 pathway. Mol. Cell 13, 879-886
49. Meulmeester, E., Pereg, Y., Shiloh, Y. and Jochemsen, A. G. (2005) ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation. Cell Cycle 4, 1166-1170
50. Meulmeester, E., Maurice, M. M., Boutell, C., Teunisse, A. F., Ovaa, H., Abraham, T. E., Dirks, R. W. and Jochemsen, A. G. (2005) Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2. Mol. Cell 18, 565-576
51. Brooks, C. L. and Gu, W. (2004) Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 3, 895-899
52. Linares, L. K., Hengstermann, A., Ciechanover, A., Muller, S. and Scheffner, M. (2003) HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl. Acad. Sci. U.S.A. 100, 12009-12014
53. Holowaty, M. N., Zeghouf, M., Wu, H., Tellam, J., Athanasopoulos, V., Greenblatt, J. and Frappier, L. (2003) Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278, 29987-29994
54. Boutell, C., Sadis, S. and Everett, R. D. (2002) Herpes simplox virus type 1 immediate-early protein ICPO and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J. Virol. 76, 841-850
55. Kato, M., Miyazawa, K. and Kitamura, N. (2000) A deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKP. J. Biol. Chem. 275, 37481-37487
56. Naviglio, S., Mattecucci, C., Matoskova, B., Nagase, T., Nomura, N., Di Fiore, P. P. and Draetta, G. F. (1998) UBPY: a growth-regulated human ubiquitin isopeptidase. EMBO J. 17, 3241-3250
57. Niendorf, S., Oksche, A., Kisser, A., Lohler, J., Prinz, M., Schorle, H., Feller, S., Lewitzky, M., Horak, I. and Knobeloch, K. P. (2007) Essential role of ubiquitin-specific protease 8 for receptor tyrosine kinase stability and endocytic trafficking in vivo. Mol. Cell. Biol. 27, 5029-5039
58. Mayer, B. J. (2001) SH3 domains: complexity in moderation, J. Cell Sci. 114, 1253-1263
59. Kaneko, T., Kumasaka, T., Ganbe, T., Sato, T., Miyazawa, K., Kitamura, N. and Tanaka, N. (2003) Structural insight into modest binding of a non-PXXP ligand to the signal transducing adaptor molecule-2 Src homology 3 domain. J. Biol. Chem. 278, 48162-48168
60. Takata, H., Kato, M., Denda, K. and Kitamura, N. (2000) A hrs binding protein having a Src homology 3 domain is involved in intracellular degradation of growth factors and their receptors. Genes Cells 5, 57-69
61. Row, P. E., Liu, H., Hayes, S., Welchman, R., Charalabous, P., Hofmann, K., Clague, M. J., Sanderson, C. M. and Urbe, S. (2007) The MIT domain of UBPY constitutes a CHMP binding and endosomal localization signal required for efficient epidermal growth factor receptor degradation. J. Biol. Chem. 282, 30929-30937
62. Tsang, H. T., Connell. J. W., Brown, S. E., Thompson, A., Reid, E. and Sanderson, C. M. (2006) A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 88, 333-346
63. Wu, X., Yen, L., Irwin, L., Sweeney, C. and Carraway, K. L., 3rd (2004) Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol. Cell. Biol. 24, 7748-7757
64. Qiu, X. B., Markant, S. L., Yuan, J. and Goldberg, A. L. (2004) Nrdp1-mediated degradation of the gigantic IAP, BRUCE, is a novel pathway for triggering apoptosis. EMBO J. 23, 800-810
65. Diamonti, A. J., Guy, P. M., Ivanof, C., Wong, K., Sweeney, C. and Carraway, K. L., 3rd (2002) An RBCC protein implicated in maintenance of steady-state neuregulin receptor levels. Proc. Natl. Acad. Sci. U.S.A. 99, 2866-2871
66. Qiu, X. B. and Goldberg, A. L. (2002) Nrdp1/FLRF is a ubiquitin ligase promoting ubiquitination and degradation of the epidermal growth factor receptor family member, ErbB3. Proc. Natl. Acad. Sci. U.S.A. 99, 14843-14848
67. Ballif, B. A., Cao, Z., Schwartz, D., Carraway, K. L., 3rd and Gygi, S.P. (2006) Identification of 14-13-3ε substrates from embryonic murine brain. J. Proteome Res. 5, 2372-2379
68. Yaffe, M. B., Rittinger, K., Volinia, S., Caron, P. R., Aitken, A., Leffers, H., Gamblin, S. J. Smerdon, S. J. and Cantley, L. C. (1997) The structural basis for 14-13-3:phosphopeptide binding specificity. Cell 91, 961-971
69. Benzinger, A., Muster, N., Koch, H. B., Yates, III, J. R. and Hermeking, H. (2005) Targeted proteomic analysis of 14-13-3σ, a p53 effector commonly silenced in cancer. Mol. Cell. Proteomics. 4, 785-795
70. Meek, S. E., Lane, W. S. and Piwnica-Worms, H. (2004) Comprehensive proteomic analysis of interphase and mitotic 14-13-3-binding proteins. J. Biol. Chem. 279, 32046-32054
71. Mizuno, E., Kitamura, N. and Komada, M. (2007) 14-13-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp. Cell Res. 313, 3624-3634
72. Khut, P. Y, Tucker, B., Lardelli, M. and Wood, S. A. (2007) Evolutionary and expression analysis of the Zebrafish deubiquitylating enzyme, Usp9. Zebrafish 4, 95-101
73. Al-Halkim, A. K., Goransson, O., Deak, M., Toth, R., Campbell, D. G., Morrice, N. A., Prescott, A. R. and Alessi, D. R. (2005) 14-13-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J. Cell Sci. 118, 5661-5673
74. Guo, S. and Kemphues, K. J. (1995) par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81, 611-620
75. Shulman, J. M., Benton. R. and St. Johnston, D. (2000) The Drosophila homolog of C. elegans PAR-1 organizes the oocyte cytoskeleton and directs oskar mRNA localization to the posterior pole. Cell 101, 377-388
76. Choe, E. A., Liao, L., Zhou, J. Y., Cheng, D., Duong, D. M., Jin, P, Tsai, L. H. and Peng, J. (2007) Neuronal morphogenesis is regulated by the interplay between cyclin-dependent kinase 5 and the ubiquitin ligase mind bomb 1. J Neurosci. 27, 9503-9512
77. Liu, N., Dansereau, D. A. and Lasko, F. (2003) Fat facets interacts with vasa in the Drosophila pole plasm and protects it from degradation. Curr. Biol. 13, 1905-1909
78. Sengoku, T., Nurelki, O., Nakamura, A., Kobayashi, S. and Yokoyama, S. (2006) Structural basis for RNA unwinding by the DEAD-box protein Drosophila Vasa. Cell 125, 287-300
79. Chen, X., Zhang, B. and Fischer, J. A. (2002) A specific protein substrate for a deubiquitinating enzyme: Liquid facets is the substrate of Fat facets. Genes Dev. 6, 289-294
80. Cadavid, A, L., Ginzel, A. and Fischer, J. A. (2000) The function of the Drosophila fat facets deubiquitinating enzyme in limiting photoreceptor cell number is intimately associated with endocytosis. Development 127, 1727-1736
81. Grunda, J. M., Nabors, L. B., Palmer, C. A., Chhieng, D. C., Steg, A., Mikkelsen, T, Diasio, R. B., Zhang, K.. Allison, D., Grizzle, W. E. et al. (2006) Increased expression of thymidylate synthetase (TS), ubiquitin specific protease 10 (USP10) and survivin is associated with poor survival in glioblastoma multiforme (GBM). J. Neurooncol. 80, 261-274
82. Soncini, C., Berdo, I. and Draetta, G. (2001) Ras-GAP SH3 domain binding protein (G3BP) is a modulator of USP10. a novel human ubiquitin specific protease. Oncogene 20, 3869-3879
83. Cohen, M., Stutz, F, Belgareh, N., Haguenauer-Tsapis, R. and Dargemont, C. (2003) Ubp3 requires a cofactor, Bre5, to specifically de-ubiquitinate the COPII protein, Sec23. Nat. Cell Biol. 5, 661-667
84. Bilsland, E., Hult, M., Bell, S. D., Sunnerhagen, P. and Downs, J. A. (2007) The Bre5/Ubp3 ubiquitin protease complex from budding yeast contributes to the cellular response to DNA damage. DNA Repair 6, 1471-1484
85. Moazed, D. and Johnson, D. (1996) A deubiquitinating enzyme interacts with SIR4 and regulates silencing in S. cerevisiae. Cell 86, 667-677
86. Wilkinson, K. D. (1997) Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. FASEB J. 11, 1245-1256
87. Li, K., Ossareh-Nazari, B., Liu, X., Dargemont, C. and Marmorstein, R. (2007) Molecular basis for bre5 cotactor recognition by the ubp3 deubiquitylating enzyme. J. Mol. Biol. 372, 194-204
88. Faus, H., Meyer, H. A., Huber, M., Bahr, I. and Haendler, B. (2005) The ubiquitin-specific protease USP10 modulates androgen receptor function. Mol. Cell. Endcrinol. 245, 138-146
89. Yamaguchi, T., Kimura, J., Milki, Y. and Yoshida, K. (2007) The deubiquitinating enzyme USP11 controls an IKB kinase a (IKKα)-p53 signaling pathway in response to tumor necrosis factor ot (TNFα). J. Biol. Chem. 282, 33943-33948
90. Bouwmeester, T, Bauch, A., Ruffner, H., Angrand, P. O., Bergamini, G., Croughton, K., Crucial, C., Eberhard, D., Gagneur, J., Ghidelli, S. et al. (2004) A physical and functional map of the human TNF-α/ NF-KB signal transduction pathway. Nat. Cell Biol. 6, 97-105
91. Dejardin, E. (2006) The alternative NF-KS pathway from biochemistry to biology: pitfalls and promises for future drug development. Biochem. Pharmacol. 72, 1161-1179
92. Dobrzanski, P, Ryseck, R. P. and Bravo, R. (1993) Both N- and C-terminal domains of ReIB are required for full transactivation: role of the N-lerminal leucine zipper-like motif. Mol. Cell. Biol. 13, 1572-1582
93. Schoenfeld, A. R., Apgar, S., Dolios, G., Wang, R. and Aaronson, S. A. (2004) BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol. Cell. Biol. 24, 7444-7455
94. Sharan, S. K., Morimatsu, M., Albrecht, U., Lim, D. S., Regel, E., Dinh, C., Sands, A., Eichele, G., Hasty, P. and Bradley, A. (1997) Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804-610
95. Elsasser, S., Chandler-Militello, D., Muller, B.. Hanna, J. and Finley, D. (2004) Rad23 and Rpn10 serve as alternative ubiquitin receptors for the proteasome. J. Biol. Chem. 279, 26817-26822
96. Shinji, S., Naito, Z., Ishiwata, S., Ishiwata, T., Tanaka, N., Furukawa, K., Suzuki, H., Seya, T., Matsuda, A., Katsuta, M. and Tajiri, T. (2006) Ubiquitin-specific protease 14 expression in colorectal Cancer is associated with liver and lymph node metastases. Oncology Rep. 15, 539-543
97. Crimmins, S., Jin, Y., Wheeler, C., Huffman, A. K., Chapman, C., Dobrunz, L. E., Levey. A., Roth, K. A., Wilson, J. A. and Wilson, S. M. (2006) Transgenic rescue of ataxia mice with neuronal-specific expression of ubiquitin-specific protease 14. J. Neurosci. 26, 11423-11431
98. Koulich, E., Li, X. and Demartino, G. N. (2008) Relative structural and functional roles of multiple deubiquitylating proteins associated with mammalian 26S proteasome. Mol. Biol. Cell 19, 1072-1082
99. Anderson, C., Crimmins, S., Wilson, J. A., Korbel, G. A., Ploegh, H. L. and Wilson, S. M. (2005) Loss of Usp14 results in reduced levels of ubiquitin in ataxia mice. J. Neurochem. 95, 724-731
100. Baker, R. T., Wang, X. W., Woollatt, E., White, J. A. and Sutherland, G. R. (1999) Identification, functional characterization, and chromosomal localization of USP15, a novel human ubiquitin-specific protease related to the UNP oncoprotein, and a systematic nomenclature for human ubiquitin-specific proteases. Genomics 59, 264-274
101. Gilchrist, C. A., Gray, D. A. and Baker, R. T. (1997) A ubiquitin-specitic protease that efficiently cleaves the ubiquitin-proline bond. J, Biol. Chem. 272, 32280-32285
102. Hetfeld, B. K., Helfrich, A., Kapelari, B., Scheel, H., Hofmann, K., Guterman, A., Glickman, M., Schade, R., Kloetzel, P. M. and Dubiel, W. (2005) The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. Curr. Blol. 15, 1217-1221
103. Cope, G. A. and Deshaies, R. J. (2003) COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114, 663-671
104. Liu, C., Powell, K. A., Mundt, K., Wu, L., Carr, A. M. and Caspari, T. (2003) Cop9/signalosome subunits and Pcu4 regulate ribonucleotide reductase by both checkpoint-dependent and -independent mechanisms. Genes Dev. 17, 1130-1140
105. Groisman, R., Polanowska, J., Kuraoka, I., Sawada, J., Saijo, M., Drapkin, R., Kisselev, A. F., Tanaka, K. and Nakatani, Y. (2003) The ubiquitin ligase activity in the DDB2 and CSA complexes is differentially regulated by the COP9 signalosome in response to DNA damage. Cell 113, 357-367
106. Schwechheimer, C. (2004) The COP9 signalosome (CSN): an evolutionary conserved proteolysis regulator in eukaryotic development. Biochim. Biophys. Acta 1695. 45-54
107. Zhou, C., Wee, S., Rhee, E.. Naumann, M., Dubiel, W. and Wolf, D. X (2003) Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubpl2p. Mol. Cell 11, 927-938
108. Li, Z., Wang, D., Na, X., Schoen, S. R., Messing, E. M. and Wu, G. (2002) Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel-Lindau tumor suppressor. Blochem. Biophys. Res. Commun. 294, 700-709
109. Li, Z., Na, X., Wang, D., Schoen, S. R., Messing, E. M. and Wu, G. (2002) Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 277, 4656-4662
110. Li, Z., Wang, D., Messing, E. M. and Wu, G. (2005) VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1α. EMBO Rep. 6, 373-378
111. Mason, S. and Johnson, R. S. (2007) The role of HIF-1 in hypoxic response in the skeletal muscle. Adv. Exp. Med. Biol. 618, 229-244
112. Zhang, X. Y., Varthi, M., Sykes, S. M., Phillips, C., Warzecha, C.. Zhu, W, Wyce, A., Thorne, A. W., Berger, S. L. and McMahon, S. B. (2008) The putative cancer stem Cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression. Mol. Cell 29, 102-111
113. Glinsky, G. V (2006) Genomic models of metastatic cancer: functional analysis of death-from-cancer signature genes reveals aneupioid, anoilkis-resistant, metastasis-enabling phenotype with altered cell cycle control and activated Polycomb Group (PcG) protein chromatin silencing pathway. Cell Cycle 5, 1208-1216
114. Lee, K. K. and Workman, J. L. (2007) Histone acetyltransterase complexes: one size doesn't fit all. Nat. Rev. 8, 284-295
115. Gavin, A. C., Bosche, M., Krause, R., Grandi, P. Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A. M., Cruciat, C. M. et al. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-147
116. Lee, K. K., Florens, L., Swanson, S. K., Washburn, M. P. and Workman, J. L. (2005) The deubiquitylation activity of Ubp8 is dependent upon Sgf11 and its association with the SAGA complex. Mol. Cell. Biol. 25, 1173-1182
117. Zhang, D., Zaugg, K., Mak, T. W. and Elledge, S. J. (2006) A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell 126, 529-542
118. Popov, N., Herold, S., Llamazares, M., Schulein, C. and Eilers, M. (2007) Fbw7 and Usp28 regulate myc protein stability in response to DNA damage. Cell Cycle 6, 2327-2331
119. Popov, N., Wanzel, M., Madiredio, M., Zhang, D., Beijersbergen, R., Bernards, R., Moll, R., Elledge, S. J. and Eilers, M. (2007) The ubiquitin-specific protease USP28 is required for MYC stabifity. Nat. Cell Biol. 9, 765-774
120. Robson, S., Pelengaris, S. and Khan, M. (2006) c-Myc and downstream targets in the pathogenesis and treatment of cancer. Recent Patents Anticancer Drug Discov. 1, 305-326
121. Curcio-Morelli, C., Zavacki, A. M., Christofollete, M., Gereben, B., de Freitas, B. C., Harney, J. W., Li, Z., Wu, G. and Bianco, A. C. (2003) Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J. Clin. Invest. 112, 189-196
122. Bignell, G. R., Warren, W., Seal, S., Takahashi, M.. Rapley, E., Barfoot, R.. Green, H., Brown, C.. Biggs, P. J., Lakhani, S. R. et al. (2000) Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25, 160-165
123. Brummelkamp, T. R., Nijman, S. M., Dirac, A. M. and Bernards, R. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB. Nature 424, 797-801
124. Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israel, A., Wallach, D. and Courtois, G. (2003) The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination. Nature 424, 801-805
125. Regamey, A., Hohl. D., Liu, J. W, Roger, T., Kogerman, P., Toftgard, R. and Huber, M. (2003) The tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor κB activation by tumor necrosis factor. J. Exp. Med. 198, 1959-1964
126. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A. and Mosialos, G. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members. Nature 424, 793-796
127. Chen, Z. J. (2005) Ubiquitin signalling in the NF-κB pathway. Nat. Cell Biol. 7, 758-765
128. Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A. and Fassler, R. (2006) Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-κB signaling. Cell 125, 665-677
129. Courtois, G. and Gilmore, T. D. (2006) Mutations in the NF-κB signaling pathway: implications for human disease. Oncogene 25, 6831-6843
130. Hibi, K., Liu, Q., Beaudry, G. A., Madden. S. L., Westra, W. H., Wehage, S. L., Yang, S. C., Heitmiller, R. F, Bertelsen, A. H., Sidransky, D. and Jen, J. (1998) Serial analysis of gene expression in non-small cell lung cancer. Cancer Res. 58, 5690-5694
131. Caballero, O. L., Resto, V., Patturajan, M., Meerzaman, D., Guo, M. Z., Engles, J., Yochem, R., Ratovitski, E., Sidransky, D. and Jen, J. (2002) Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). Oncogene 21, 3003-3010
132. Li, T., Duan, W., Yang, H., Lee, M. K., Bte Mustafa, F., Lee, B. H. and Teo, T. S. (2001) Identification of two proteins, S14 and UIP1, that interact with UCH37. FEBS Left. 488, 201-205
133. Yao, T., Song, L., Xu, W., DeMartino, G. N., Florens, L., Swanson, S. K., Washburn, M. P., Conaway, R. C., Conaway, J. W. and Cohen, R. E. (2006) Proteasome recruitment and activation of the Uch37 deubiquitinating enzyme by Adrm1. Nat. Cell Biol. 8, 994-1002
134. Wicks, S. J., Haros, K., Maillard, M., Song, L., Cohen, R. E., Dijke, P.T. and Chantry, A. (2005) The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-β signalling. Oncogene 24, 8080-8084
135. Wicks, S. J., Grocott, T., Haros, K., Maillard, M., ten Dijke, P. and Chantry, A. (2006) Reversible ubiquitination regulates the Smad/ TGF-β signalling pathway. Biochem. Soc. Trans. 34, 761-763
136. Jensen, D., E. and Rauscher, III, F. J. (1999) Defining biochemical functions for the BRCA1 tumor suppressor protein: analysis of the BRCA1 binding protein BAP1. Cancer Lett. 143, (Suppl. 1), S13-S17
137. Beyaert, R., Heyninck, K. and Van Huffel, S. (2000) A20 and A20-binding proteins as cellular inhibitors of nuclear factor-κB-dependent gene expression and apoptosis. Biochem. Pharmacol. 60, 1143-1151
138. Heyninck, K., De Valck, D., Vanden Berghe, W., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G. and Beyaert, R. (1999) The zinc finger protein A20 inhibits TNF-induced NF-κB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-κB-inhibiting protein ABIN. J. Cell Biol. 145, 1471-1482
139. Hurley, J. H., Lee. S. and Prag, G. (2006) Ubiquitin-binding domains. Biochem. J. 399, 361-372
140. Wertz, I. E., O'Rourke, K. M., Zhou, H., Eby, M., Aravind, L., Seshagiri, S., Wu, P., Wiesmann, C., Baker, R., Boone, D. L. et al. (2004) De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699
141. Song, H. Y., Rothe, M. and Goeddel, D. V. (1996) The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 93, 6721-6725
142. Ely, K. R., Kodandapani, R. and Wu, S. (2007) Protein-protein interactions in TRAF3. Adv. Exp. Med. Biol. 597, 114-121
143. Evans, P. C., Taylor, E. R., Coadwell, J., Heyninck, K., Beyaert, R. and Kilshaw, P. J. (2001) Isolation and characterization of two novel A20-like proteins. Biochem. J. 357, 617-623
144. Evans, P. C., Ovaa, H., Hamon, M., Kilshaw, P. J., Hamm, S., Bauer, S., Ploegh, H. L. and Smith, T. S. (2004) Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378, 727-734
145. Uchiyama, K., Jokitalo, E., Kano, F., Murata, M., Zhang, X., Canas. B., Newman, R., Rabouille, C., Pappin, D., Freemont, P. and Kondo, H. (2002) VCIP135, a novel essential factor for p97/p47-mediated membrane fusion, is required for Golgi and ER assembly in vivo. J. Cell Biol. 159, 855-866
146. Wang, Y., Satoh, A., Warren, G. and Meyer, H. H. (2004) VCIP135 acts as a deubiquitinating enzyme during p97-p47-mediated reassembly of mitotic Golgi fragments. J. Cell Biol. 164, 973-978
147. Kano, F., Kondo, H., Yamamoto, A., Kaneko, Y., Uchiyama, K., Hosokawa, N., Nagata, K. and Murata, M. (2005) NSF/SNAPs and p97/p47/VCIP135 are sequentially required for cell cycle-dependent reformation of the ER network. Genes Cells 10, 989-999
148. Mao, Y., Senic-Matuglia, F., Di Fiore, P. P., Polo, S., Hodsdon, M. E. and De Camilli, P. (2005) Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc. Natl. Acad. Sci. U.S.A. 102, 12700-12705
149. Heir, R., Ablasou, C., Dumontier, E., Elliott, M., Fagotto-Kaulfmann, C. and Bedford, F. K. (2006) The UBL domain of PLIC-1 regulates aggresome formation. EMBO Rep. 7, 1252-1258
150. Evert, B. O., Araujo, J., Vieira-Saecker, A. M., de Vos, R. A., Harendza, S., Klockgether, T. and Wullner, U. (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci. 26, 11474-11486
151. Li, F., Macfarlan, T., Pittman, R. N. and Chakravarti, D. (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem. 277, 45004-45012
152. McCullough, J., Clague, M. J. and Urbe, S. (2004) AMSH is an endosome-associated ubiquitin isopeptidase. J. Cell Biol. 166, 487-492
153. McCullough, J., Row, P. E., Lorenzo, O., Doherty, M., Beynon, R., Clague, M. J. and Urbe, S. (2006) Activation of the endosome-associated ubiquitin isopeptidase AMSH by STAM, a component of the multivesicular body-sorting machinery. Curr. Biol. 16, 160-165
154. Agromayor, M. and Martin-Serrano, J. (2006) Interaction of AMSH with ESCRT-III and deubiquitination of endosomal cargo. J. Biol. Chem. 281, 23083-23091
155. Kim, M. S., Kim, J. A., Song, H. K. and Jeon, H. (2006) STAM-AMSH interaction facilitates the deubiquitination activity in the C-terminal AMSH. Biochem. Biophys. Res. Commun. 351, 612-618
156. Kyuuma, M., Kikuchi, K., Kojima, K., Sugawara, Y., Sato, M., Mano, N., Goto, J., Takeshita, T., Yamamoto, A., Sugamura, K. and Tanaka, N. (2007) AMSH, an ESCRT-III associated enzyme, deubiquitinates cargo on MVB/late endosomes. Cell Struct. Funct. 31, 159-172
157. Berndt, C., Bech-Otschir, D., Dubiel, W. and Seeger, M. (2002) Ubiquitin system: JAMMing in the name of the lid. Curr. Biol. 12, R815-R817
158. Wolf, D. H. and Hilt, W. (2004) The proteasome: a proteolytic nanomachine of cell regulation and waste disposal. Biochim. Biophys. Acta 1695, 19-31
159. Glickman, M. H., Rubin, D. M., Coux, O., Wefes, I., Pfeifer, G., Cjeka, Z., Baumeister, W., Fried, V. A. and Finley, D. (1998) A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94, 615-623
160. Guterman, A. and Glickman, M. H. (2004) Deubiquitinating enzymes are IN/ (trinsic to proteasome function). Curr. Protein Pept. Sci. 5, 201-211
161. Leggett, D. S., Hanna, J., Borodovsky, A., Crosas, B., Schmidt, M., Baker, R. T., Walz, T., Ploegh, H. and Finley, D. (2002) Multiple associated proteins regulate proteasome structure and function. Mol. Cell 10, 495-507
162. Lam, Y. A., Xu, W., DeMartino, G. N. and Cohen, R. E. (1997) Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome. Nature 385, 737-740
163. Stone, M., Hartmann-Petersen, R., Seeger, M., Bech-Otschir, D., Wallace, M. and Gordon, C. (2004) Uch2/Uch37 is the major deubiquitinating enzyme associated with the 26S proteasome in fission yeast. J. Mol. Biol. 344, 697-706
164. Chernova, T. A., Allen, K. D., Wesoloski, L. M., Shanks, J. R., Chernoff, Y. O. and Wilkinson, K. D. (2003) Pleiotropic effects of Ubp6 loss on drug sensitivities and yeast prion are due to depletion of the free ubiquitin pool. J. Biol. Chem. 278, 52102-52115
165. Kraut, D. A., Prakash, S. and Matouschek, A. (2007) To degrade or release: ubiquitin-chain remodeling. Trends Cell Biol. 17, 410-421